TUM – Technical University of Munich Menu
PhD student Pamina Kazman examines the folding and stability of antibody domains with the circular dichroism spectrometer of the Chair of Biotechnology.
PhD student Pamina Kazman examines the folding and stability of antibody domains with the circular dichroism spectrometer of the Chair of Biotechnology.
Image: A. Heddergott / TUM
  • Research news
  • Reading time: 2 MIN

Mutations in plasma cells play a key role in light chain amyloidosisFatal overproduction of antibodies

Bone marrow plasma cells produce antibodies. These comprise two long and two short protein chains. The pathological proliferation of plasma cells can lead to an overproduction of the short chains. These associate to fibrils and deposit in organs. The result is fatal organ failure. A research team from the Technical University of Munich (TUM) and Heidelberg University has now identified the mutation behind the disease in a patient.

Antibodies are vital for the survival of human beings. They typically consist of two longer and thus heavier amino acid chains and two lighter ones. In rare cases, the plasma cells multiply excessively, flooding the body with light antibody chains.

In people suffering from light chain amyloidosis (AL amyloidosis), these light chains are deposited as extremely fine fibers, so-called amyloid fibrils, in tissue or in organs. The disease is often recognized only after the deposits already compromise the function of organs. In many cases AL amyloidosis is fatal.

"To date, little was known about the exact cause of this amyloidosis," says Johannes Buchner, professor of biotechnology at the Technical University of Munich. “Depending on the organ affected, the symptoms vary considerably. Furthermore, each patient produces different types of antibodies. The disease is thus difficult to diagnose at an early stage.”

A mutation triggers the deadly disease

Using various analytical and database-supported methods, the team of scientists succeeded in identifying eleven mutations caused by the disease in the antibodies of a patient with advanced AL amyloidosis.

Further investigations showed that exactly one mutation was responsible for the destabilization and formation of the disease-causing amyloid fibrils. This mutation causes the unstable light chain to lose its structure after breaking into fragments, which then form the deadly amyloid fibrils.

"Our study shows that mutations that lead to unstable light chains are an important factor in the occurrence of amyloidosis," says Pamina Kazman, who carried out the majority of the measurements. "In the long term, we hope that these and other studies will lead to new, earlier diagnostic methods and possibly even new treatment options."

Publications:

Fatal amyloid formation in a patient’s antibody light chain is caused by a single point mutation
Pamina Kazman, Marie-Theres Vielberg, María Daniela Pulido Cendales, Lioba Hunziger, Benedikt Weber, Ute Hegenbart, Martin Zacharias, Rolf Köhler, Stefan Schönland, Michael Groll, Johannes Buchner
eLife, online: 10.03.2020

More information:

The research was funded by the German Research Foundation (DFG). The protein structures were determined at the synchrotron radiation sources of the Paul Scherrer Institute in Villigen (Switzerland) and the European synchrotron radiation source in Grenoble (France).

High resolution images

Corporate Communications Center

Technical University of Munich Dr. Andreas Battenberg
battenberg(at)zv.tum.de

Contacts to this article:

Prof. Dr. Johannes Buchner
Professorship of Biotechnology
Technical University of Munich
Lichtenbergstr. 4, 85748 Garching, Germany
Tel.: +49 89 289 13340 – johannes.buchner(at)tum.de

Article at tum.de

Human αA-crystallin forms structures of 12, 16 and 20 subunits (from left to right). Two subunits (center, dark and light gray) form a dimer.

Guardian angel of the eye

The lens of the human eye comprises a highly concentrated protein solution, which lends the lens its great refractive power. Protective proteins prevent these proteins from clumping together throughout a lifetime. A team of...

[Translate to en:]

Chaperones keep the tumor suppressor protein p53 in check

The anti tumor protein p53 can decide on the life or death of a cell: If it detects damage in the cell's genome, the protein pushes the cell to suicide. New research conducted at Technical University of Munich (TUM) shows...

Räumliche Struktur des alphaB-Crystallins, eine hexamere Untereinheit ist farblich heraus gehoben – Bild: Andi Mainz / TUM

New field of application for versatile helper

In Alzheimer’s disease proteins clump together to long fibrils causing the death of nerve cells. Small heat shock proteins can counteract this effect. Scientists, therefore, hope to deploy them as agents in the treatment of...

Fertigbauprinzip: 32 identische Untereinheiten bilden diese Form des Proteinkomplexes Sip1 – Bild: Tilly Fleckenstein / TUM

A protein provides emergency aid

Small heat shock proteins ensure that other proteins do not clot, allowing the cell to survive stress. Defects in these “small helpers” are associated with medical conditions like cataracts and cancer. Now, scientists at...

Strukturelles Modell des IgNAR Hai-Antikörpers – Bild: Janosch Hennig, TUM/Helmholtz Zentrum

Learning from sharks

Genetically engineered antibodies are deployed successfully in cancer diagnostics and therapy. Therapeutic antibodies against Alzheimer’s disease and multiple sclerosis are currently under development. An important...

Speicherform (24mer) und aktive Formen des αB-Crystallins, die vor grauem Star schützen

A protein safeguards against cataracts

The refractive power of the human eye lens relies on a densely packed mixture of proteins. Special protective proteins ensure that these proteins do not clump together as time passes. When this protective mechanism fails,...